Back To: Home : Featured Technology : Stem Cell

CLICK HERE FOR WHAT'S NEW IN:
 

Plasticell, Stemnion complete stem cell collaboration
September 2011
SHARING OPTIONS:

LONDON—Biotechnology company Plasticell, which specializes in high-throughput technologies for directed stem cell differentiation, recently announced that it successfully completed a collaboration with Pittsburgh, Pa.-based Stemnion Inc., a regenerative medicine company that focuses on therapeutic products obtained from amnion-derived, non-embryonic stem cells, also known as placental stem cells. Through use of its flagship technology CombiCult, Plasticell discovered multiple novel, serum-free protocols responsible for directing the differentiation of Stemnion's stem cells into hard-to-obtain lineages. The protocols were then ranked with Plasticell's Ariadne bioinformatics software and validated by Stemnion's scientists.

Dr. Lilian Hook, director of research at Plasticell, said in a press release that "Stemnion provided us with a challenge that is typical of adult stem cell R&D programs, however, this project was particularly interesting on several fronts, including, for the first time, utilizing placenta-derived stem cells as the starting cell-type."


Back


PAGE UTILITIES


CONTACT US
DDNEWS
Published by Old River Publications LLC
19035 Old Detroit Road
Rocky River, OH USA 44116
Ph: 440-331-6600  |  Fax: 440-331-7563
 
© Copyright 2018 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.